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Abstract
Background: Dental surgery can be carried out on patients under oral anticoagulation therapy by
using haemostyptic measures. The aim of the study was a comparative analysis of coagulation by
laboratory methods and immediate patient diagnosis on the day of the planned procedure.
Methods: On the planned day of treatment, diagnoses were carried out on 298 patients for
Prothrombin Time (PT), the International Normalised Ratio (INR), and Partial Thromboplastin
Time (PTT). The decision to proceed with treatment was made with an INR < 4.0 according to
laboratory results.
Results: Planned treatment did not go ahead in 2.7% of cases. Postoperatively, 14.8% resulted in
secondary bleeding, but were able to be treated as out-patients. 1.7% had to be treated as in-
patients. The average error between the immediate diagnosis and the laboratory method: 95%
confidence interval was -5.8 ± 15.2% for PT, -2.7 ± 17.9 s for PTT and 0.23 ± 0.80 for INR. The
limits for concordance were 9.4 and -21.1% for PT, 15.2 and -20.5 s for PTT, and 1.03 and -0.57
for INR.
Conclusion: This study showed a clinically acceptable concordance between laboratory and
immediate diagnosis for INR. Concordance for PT and PTT did not meet clinical requirements. For
patients under oral anticoagulation therapy, patient INR diagnosis enabled optimisation of the
treatment procedure when planning dental surgery.
Background
To prevent thrombosis and embolism, patients are treated
increasingly as out-patients and are sometimes given anti-
coagulant therapy for many years. The anticoagulant with
coumarin derivatives is widely distributed. As vitamin K
antagonists, these derivatives inhibit the g-carboxylation
of glutamic acids in the synthesis of coagulation factors II,
VII, IX and X in the liver. With regards to comparability
and standardisation of test results for oral anticoagulation
therapy, the International Normalised Ratio (INR) is rec-
ommended by WHO for monitoring of patients' coagula-
tion physiology. INR values between 2.0 and 3.0 are
recommended for thromboembolic illnesses, atrial fibril-
lation, heart valve diseases and myocardial infarct. For
mechanical heart valves and recurring embolism, an INR
value between 2.5 and 3.5 is set.
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example, only present a significant risk for patients under
anticoagulation therapy in exceptional cases [7]. In con-
trast, stopping anticoagulation therapy independently
before dental surgery procedures can present patients with
unnecessary life-threatening risks from thromboembo-
lism [27]. With INR values for therapy between 2.0 and
3.5, extractions of one or more teeth and uncomplicated
osteotomies, taking into account relevant local haemosta-
sis methods without danger of haemorrhaging, are possi-
ble [12], whereby the INR value is to be determined pre-
operatively on the day of operation [21]. For immediate
patient diagnosis of the coagulation status, instruments
have been developed which are used in operating theatres
and in intensive care [18]. The same systems are used by
patients to self-monitor oral anticoagulation [1,17]. The
aim of this study was a comparative analysis of coagula-
tion and treatment planning for immediate diagnosis of
patients and diagnosis in the main laboratory.
Methods
Patients
A total of 298 patients who received dental treatment
under anticoagulation therapy were included in this
study. The period of acquisition reached from 10.10.2002
to 16.04.2004. The group tested consisted of 106 women
and 192 men with an age range of 11–91 years and an
average age of 60.1 years. Anticoagulation treatment was
carried out after thromboembolic illnesses (30.5%), atrial
fibrillation (27.4%), myocardial infarct (15.1%) and
heart valve replacement (34.0%). Coumarin therapy was
carried out for 92.4% of patients. 6.6% were treated under
general anaesthesia and oral anticoagulation was admin-
istered by intravenous heparin. Additional inhibition of
thrombocyte aggregation by acetylsalicylic acid or ticlopi-
dine occurred for 2.7%. The decision to proceed with
treatment was made with an INR < 4.0 according to labo-
ratory results [2]. 83.0% of patients underwent surgery,
where predominantly a single tooth was extracted and
small osteotomies were carried out. 28.3% received pres-
ervation treatment, 9.4% prosthetic treatment and 10.4%
periodontal treatment. To protect against an increased risk
of intra- and postoperative complications with cardiovas-
cular diseases, 56.7% were administered intravenously
and 39.7% were put under ECG monitoring. Endocarditis
prophylaxis was carried out for 43.4% in accordance with
the guidelines of the German Society for Heart Diseases.
Local haemostyptic measures consisted of sealing the
thick wound in a collagen dressing (66.0%), a fibrin adhe-
sive (27.4%), and the use of a protective plate (18.9%). A
local flap coverage was used in 15.1% of cases.
Table 1: Frequency of secondary bleeding concerning additional 
surgical treatment options
no bleeding secondary bleeding
suture 88.9% 11.1%
collagen dressing 92.3% 7.7%
fibrin adhaesive 85.0% 15.0%
local flap coverage 66.7% 33.3%
Immediate (CoaguChek) and laboratory diagnosis of INR conc rning secondary bleedingFigure 1
Immediate (CoaguChek) and laboratory diagnosis of INR 
concerning secondary bleeding.
Correlation of immediate (CoaguChek) and laboratory diag-nosis of Prothro bin Time (PT) [%] (Pearsons c efficient r = 0.93)Figure 2
Correlation of immediate (CoaguChek) and laboratory diag-
nosis of Prothrombin Time (PT) [%] (Pearsons coefficient r = 
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Patients' intra- and postoperative trends were recorded
and complications were documented. Before treatment,
capillary blood was extracted. The diagnosis for Pro-
thrombin Time (PT), International Normalised Ration
(INR) and Partial Thromboplastin Time (PTT) was carried
out with a CoaguChek Pro device (Roche Diagnostics,
Mannheim, Germany). CoaguChek Pro PT cassettes con-
tain thromboplastin from rabbit brains (ISI 2.04). As a
PTT reagent, cow brain sulphatide was used as an activa-
tor, and soya phosphatide as a platelet substitute. The
measuring principle of the machine is based on laser-pho-
tometric detection of erythrocyte movement, which is sus-
pended when coagulation begins to set in. Measurement
and quality control were carried out, in accordance with
the manufacturer's instructions, by 3 experienced assistant
medical technicians. At the same time, blood tests were
taken in the coagulation tubes (0.106 mol/l citrate, 10%)
and analysed in the clinic's main laboratory. Both the PT
and PTT diagnoses were carried out with a BCS coagula-
tion analyser (Dade Behring, Marburg, Germany). Throm-
borel S (tissue factor from a human placenta, ISI 1.09)
and Pathromtin SL (Dade Behring, Marburg, Germany)
were used as reagents.
Analysis and statistics
The test results were analysed by a thorough data analysis
with determination of average values and standard devia-
tions. As a cohesive measurement between the parame-
ters, the correlation coefficient r with the corresponding
test (HO: r = 0) was used. With p values < 0.01 the corre-
lation was accepted. Selected parameter combinations
were depicted in range diagrams with the corresponding
regression line. The concordance between measurement
methods was analysed in accordance with Bland and Alt-
man [3]. Average and relative errors and the absolute and
relative limits of concordance were calculated and
depicted in diagram form. When comparing methods, a
relative error of ± 10% and relative limits of concordance
at ± 25% were assessed to be clinically acceptable [19].
Correlation of immediate diagnosis (CoaguChek) of the Pro-thrombin Time (PT) [%] and the International Normalised Ratio (INR) (Spearman coefficient r = -0.89)Figure 5
Correlation of immediate diagnosis (CoaguChek) of the Pro-
thrombin Time (PT) [%] and the International Normalised 
Ratio (INR) (Spearman coefficient r = -0.89)
Correlation of immediate (CoaguChek) and laboratory diag-nosis of the International Normalised Ratio (INR) (Pearsons c efficient r = 0.86)Figure 4
Correlation of immediate (CoaguChek) and laboratory diag-
nosis of the International Normalised Ratio (INR) (Pearsons 
coefficient r = 0.86)
Correlation of immediate (CoaguChek) and laboratory diag-nosis of Partial Thromboplastin Time (PTT) [s] (Pearsons c efficient = 0.74)Figure 3
Correlation of immediate (CoaguChek) and laboratory diag-
nosis of Partial Thromboplastin Time (PTT) [s] (Pearsons 
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Planned treatment did not go ahead in 2.7% of cases.
2.3% also had an INR value > 4.0 in immediate diagnosis.
2.3% of immediate diagnoses were in the same measure-
ment range; laboratory diagnoses gave an INR value > 4.0.
Intra-operatively, there was the complication of one
major haemorrhage. Postoperatively, 14.8% resulted in
secondary bleeding, but were able to be treated as out-
patients. 1.7% had to be treated as in-patients.
No significant difference was determined in coagulation
values for patients who did and did not suffer secondary
bleeding (Fig. 1). On analysis of postoperative secondary
bleeding within the category of the "additional operative
measures" variable, a high proportion (33.3%) was
treated with a local flap reconstruction (Tab. 1).
Fig. 2 shows the range diagram of PT diagnoses from
CoaguChek and the laboratory with linear regression and
confidence interval. The results for PTT and INR are
shown in the same way in Fig. 3 and Fig. 4. The correlation
of CoaguChek PT and INR values show a charge-depend-
ent difference in the curve progression (Fig. 5).
The relative error between the laboratory and immediate
determination method ± 95% confidence interval was -
5.8 ± 15.2% for PT (Fig. 6), -2.7 ± 17.9 s for PTT (Fig. 7)
and 0.23 ± 0.80 for INR (Fig. 8). The limits for concord-
ance were 9.4 and -21.1% for PT, 15.2 and -20.5 s for PTT,
and 1.03 and -0.57 for INR.
The relative error between the laboratory methods and
immediate diagnosis was 21.3% with an average PT of
34.5%, 6.3% with an average PTT of 47.2 s, and 7.6% with
an average INR of 2.77. The relative limit for concordance
between laboratory methods and immediate diagnosis
was 48.6% for PT, 35.7% for PTT and 24.3% for INR.
Discussion
The proportion of patients with postoperative secondary
bleeding is comparable with the literature [2,6,16] as
regards local haemostyptic measures used. Good results
were established from the collagen dressing and the use of
fibrin adhesive or tranexamic acid in various studies
[4,6,15,22,26]. The plastic cover doubled the frequency of
secondary bleeding and should therefore be reserved for
the cover of maxillary sinus connection for the treatment
of patients under oral anticoagulation therapy. Studies on
the precision of measurement devices for patient diagno-
sis of the coagulation status established a firm concord-
ance with laboratory results [5,25], whereby correlation
analyses were mostly used for assessment of the concord-
ance. Neither the determination of the correlation coeffi-
cient nor the implementation of a regression analysis are
considered to be suitable measures for comparing meas-
urement methods [3]. A lower average error with INR
diagnosis with a partially more marked distribution of
values was established [1,24]. Measurement devices that
used thromboplastin with an ISI value > 2.0 showed a
decrease in concordance with comparative tests
[11,13,23].
Concordance for PTT diagnoses are also the subject of
controversial discussion. There are also studies on good
concordance [20], as well as studies on large deviations
between laboratory and immediate diagnoses [9,18,19].
Relative error between the laboratory and immediate deter-mination method concerning Partial Thromboplastin Time (PTT)Figure 7
Relative error between the laboratory and immediate deter-
mination method concerning Partial Thromboplastin Time 
(PTT).
Relative error between the laboratory and immediate deter-mination method concerning Prothrombin ti e (PT)Figure 6
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regarded as clinically acceptable for PTT and INR. The PT
diagnosis was clearly above the required value, which can
partly be traced back to the charge-specific differences in
calibration. The relative limits of concordance at 25%
could only be maintained for INR. For PT and PTT the
limit was exceeded. Comparable results for INR diagnoses
as regards the average error and the limits of concordance
were published, whereby clear differences were given at
four research centres [8]. In previous studies, a positive
average error with an increase in rising INR values was
established from the difference between immediate and
laboratory diagnoses [14]. A short treatment time using
oral anticoagulation was given as a possible cause, which
must not be assumed in the current study regarding pre-
dominantly long-term treatment. There is a possible error
in the use of thromboplastins of differing sensitivity and
the lack of calibration of the ISI with immediate diagnosis
[10].
Conclusion
In conclusion, patient INR diagnosis with the CoaguChek
Pro device allows for clinically acceptable optimisation of
the treatment procedure when planning dental surgery for
patients under oral anticoagulation therapy.
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